House Appropriators Push For Revised Pediatric Cough/Cold Labels
This article was originally published in The Tan Sheet
Executive Summary
House appropriators want FDA to propose by Dec. 31 revised labeling for OTC pediatric cough and cold products that addresses safety and efficacy concerns.
You may also be interested in...
In Brief
Committee demands final sunscreen rule
Firms Consult FDA, Add “Do Not Use” For Under 4 To Pediatric Cold Products
Over-the-counter pediatric cough/cold products relabeled "do not use" for children under 4 will reach shelves in the next few weeks in a voluntary program manufacturers coordinated with FDA
FDA Panel Narrowly Votes Against Cough/Cold Drugs For Children Up To Age 6
An FDA advisory panel decided in split votes Oct. 19 to recommend immediately that all OTC cough/cold medicines should not be used for 2-to 5-year-old children but are safe for 6- to 12-year-olds